PPD Inc. [NASDAQ: PPD] traded at a high on 04/14/21, posting a 12.10 gain after which it closed the day’ session at $43.00. The company report on April 13, 2021 that AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for Grade 1 Immune Checkpoint Inhibitor-Associated Colitis.
Phase 1b/2a Study Expected to Begin In 2Q 2021.
AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that it has entered into an agreement with PPD, Inc. (NASDAQ: PPD), a leading global contract research organization (CRO), for its planned Phase 1b/2a clinical trial evaluating proprietary formulations of micronized niclosamide for grade 1 colitis and diarrhea in oncology patients receiving treatment with immune checkpoint inhibitors (ICIs).
The results of the trading session contributed to over 3284381 shares changing hands. Over the past one week, the price volatility of PPD Inc. stands at 4.60% while the volatility over the past one month is 3.41%.
The market cap for PPD stock reached $14.89 billion, with 348.58 million shares outstanding and 158.64 million shares in the current float. Compared to the average trading volume of 1.04M shares, PPD reached a trading volume of 3284381 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about PPD Inc. [PPD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PPD shares is $41.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PPD stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Barclays have made an estimate for PPD Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on March 03, 2021. The new note on the price target was released on October 12, 2020, representing the official price target for PPD Inc. stock. Previously, the target price had yet another raise to $35, while KeyBanc Capital Markets analysts kept a Overweight rating on PPD stock. On March 23, 2020, analysts decreased their price target for PPD shares from 30.50 to 20.
The Average True Range (ATR) for PPD Inc. is set at 1.44, with the Price to Sales ratio for PPD stock in the period of the last 12 months amounting to 3.41. Price to Free Cash Flow for PPD in the course of the last twelve months was 50.50 with Quick ratio for the last quarter at 1.10.
How has PPD stock performed recently?
PPD Inc. [PPD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.55. With this latest performance, PPD shares gained by 14.94% in over the last four-week period, additionally plugging by 17.10% over the last 6 months – not to mention a rise of 86.15% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PPD stock in for the last two-week period is set at 75.30, with the RSI for the last a single of trading hit 82.32, and the three-weeks RSI is set at 70.24 for PPD Inc. [PPD]. The present Moving Average for the last 50 days of trading for this stock 36.76, while it was recorded at 39.18 for the last single week of trading, and 34.27 for the last 200 days.
PPD Inc. [PPD]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and PPD Inc. [PPD] shares currently have an operating margin of +12.75 and a Gross Margin at +43.67. PPD Inc.’s Net Margin is presently recorded at +8.68.
Return on Total Capital for PPD is now 9.72, given the latest momentum, and Return on Invested Capital for the company is 9.72. Return on Equity for this stock inclined to 9.72, with Return on Assets sitting at 6.35. When it comes to the capital structure of this company, PPD Inc. [PPD] has a Total Debt to Total Equity ratio set at 0.00. Additionally, PPD Total Debt to Total Capital is recorded at 0.00, with Total Debt to Total Assets ending up at 0.00. Long-Term Debt to Equity for the company is recorded at 0.00, with the Long-Term Debt to Total Capital now at 0.00.
Reflecting on the efficiency of the workforce at the company, PPD Inc. [PPD] managed to generate an average of $11,609 per employee. Receivables Turnover for the company is 3.29 with a Total Asset Turnover recorded at a value of 0.73.PPD Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.10 and a Current Ratio set at 1.10.
Earnings analysis for PPD Inc. [PPD]
With the latest financial reports released by the company, PPD Inc. posted 0.24/share EPS, while the average EPS was predicted by analysts to be reported at 0.21/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 14.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PPD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for PPD Inc. go to 17.22%.
Insider trade positions for PPD Inc. [PPD]
There are presently around $11,549 million, or 77.10% of PPD stock, in the hands of institutional investors. The top three institutional holders of PPD stocks are: H&F CORPORATE INVESTORS VII, LTD. with ownership of 77,118,535, which is approximately 0% of the company’s market cap and around 0.20% of the total institutional ownership; CARLYLE GROUP INC., holding 55,722,733 shares of the stock with an approximate value of $2.14 billion in PPD stocks shares; and H&F CORPORATE INVESTORS VIII, LTD., currently with $2.14 billion in PPD stock with ownership of nearly New of the company’s market capitalization.
Positions in PPD Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 143 institutional holders increased their position in PPD Inc. [NASDAQ:PPD] by around 73,427,122 shares. Additionally, 82 investors decreased positions by around 13,041,142 shares, while 14 investors held positions by with 214,609,674 shares. The mentioned changes placed institutional holdings at 301,077,938 shares, according to the latest SEC report filing. PPD stock had 77 new institutional investments in for a total of 61,772,232 shares, while 30 institutional investors sold positions of 2,543,495 shares during the same period.